scispace - formally typeset
P

Pierre Blanchard

Researcher at Institut Gustave Roussy

Publications -  314
Citations -  7989

Pierre Blanchard is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 36, co-authored 272 publications receiving 6015 citations. Previous affiliations of Pierre Blanchard include Institut national de la recherche agronomique & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

Pierre Blanchard, +26 more
- 01 Jun 2015 - 
TL;DR: The results confirm that the addition of concomitant chemotherapy to radiotherapy significantly improves survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Journal ArticleDOI

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

Pierre Blanchard, +6 more
- 01 Jul 2011 - 
TL;DR: The benefit of the addition of chemotherapy to locoregional treatment is consistent in all tumour locations of HNSCC, with hazard ratios between 0.87 and 0.88 and the higher benefit of concomitant schedule was demonstrated only for oropharyngeal and laryngeAl tumours but this may be only a consequence of a lack of power.
Journal ArticleDOI

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

Caroline Charlier, +1778 more
- 01 May 2017 - 
TL;DR: Evidence of a significantly reduced survival in patients with neurolisteriosis treated with adjunctive dexamethasone is found, and the time window for fetal losses is determined, which is higher than reported elsewhere.
Journal ArticleDOI

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): An open-label phase 3 randomised trial

Jean Bourhis, +27 more
- 01 Feb 2012 - 
TL;DR: Concomitant chemoradiotherapy and accelerated radiotherapy independently improve outcomes for patients with locally advanced head and neck squamous-cell carcinoma, but acceleration of radiotherapy cannot compensate for the absence of chemotherapy.
Journal ArticleDOI

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis

Laureen Ribassin-Majed, +19 more
- 10 Feb 2017 - 
TL;DR: The addition of AC to CRT achieved the highest survival benefit and consistent improvement for all end points, and the addition of IC toCRT achieve the highest effect on DC.